Anais Brasileiros de Dermatologia (Jun 2015)

Anti-TNF-α and hydralazine drug-induced lupus

  • Maria Victória Quaresma,
  • Fred Bernardes Filho,
  • Fernanda Brandão de Oliveira,
  • Mercedes Prates Pockstaller,
  • Maria Fernanda Reis Gavazzoni Dias,
  • David Rubem Azulay

DOI
https://doi.org/10.1590/abd1806-4841.20153893
Journal volume & issue
Vol. 90, no. 3 suppl 1
pp. 125 – 129

Abstract

Read online Read online

AbstractDrug-induced lupus is a rare drug reaction featuring the same symptoms as idiopathic lupus erythematosus. Recently, with the introduction of new medicines in clinical practice, an increase in the number of illness-triggering implicated drugs has been reported, with special emphasis on anti-TNF-α drugs. In the up-to-date list, almost one hundred medications have been associated with the occurrence of drug-induced lupus. The authors present two case reports of the illness induced respectively by hydralazine and infliximab, addressing the clinical and laboratorial characteristics, diagnosis, and treatment.

Keywords